| 000 | 01641 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515061419.0 | ||
| 264 | 0 | _c20070913 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a1077-4114 | ||
| 024 | 7 |
_a10.1097/MPH.0b013e3180335bcb _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMitsiakos, George | |
| 245 | 0 | 0 |
_aIs the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. _h[electronic resource] |
| 260 |
_bJournal of pediatric hematology/oncology _cMar 2007 |
||
| 300 |
_a145-50 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aBlood Coagulation Disorders _xblood |
| 650 | 0 | 4 | _aBlood Coagulation Tests |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 |
_aFactor VII _xadministration & dosage |
| 650 | 0 | 4 | _aFactor VIIa |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHemorrhage _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPapaioannou, Georgia | |
| 700 | 1 | _aGiougi, Evagelia | |
| 700 | 1 | _aKaragianni, Paraskevi | |
| 700 | 1 | _aGaripidou, Vassilia | |
| 700 | 1 | _aNikolaidis, Nikolaos | |
| 773 | 0 |
_tJournal of pediatric hematology/oncology _gvol. 29 _gno. 3 _gp. 145-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MPH.0b013e3180335bcb _zAvailable from publisher's website |
| 999 |
_c16912329 _d16912329 |
||